Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome – a single center experience (preliminary study)
Journal Title: Progress in Health Sciences - Year 2014, Vol 4, Issue 1
Abstract
Introduction: Mycophenolate mofetil (MMF) is used in treatment of idiopathic nephrotic syndrome in children (INS). Purpose: To evaluate clinical results of MMF treatment in steroid-dependent (SD) and steroid-resistant (SR) nephrotic syndrome. Materials and methods: A retrospective analysis of 26 patients (19 boys, 7 girls) with SDINS and SRINS treated with MMF during the years 2003–2013 was made. The remission length of INS and number of relapses per year before the introduction of MMF and after 12 months was calculated. An analysis of the side effects was made. Results: The median age of INS diagnosis was 26.5 months (IQRs 24-36 months). Nineteen of the patients (73%) suffered from SDINS whereas the remaining 7 (27%) had SRINS. Twenty three (88.5%) patients underwent renal biopsy: minimal change disease (MCD) in 69.6% (n=16), focal segmental glomerulosclerosis (FSGS) in 17.4% (n=4), membranoproliferative glomerulonephritis (MPGN) in 8.7% (n=2) and mesangial cell proliferation in one case. The median MMF dosage was 956.0 mg/m2/24h (IQRs 768.1-1059.7 mg/m2/24h). Eleven patients (42.3%) were taking MMF together with cyclosporine A (CsA). In patients suffering from SDINS, there was a trend to lower the recurrence rate during MMF treatment [2.0/year (IQRs 0.25-2.0 per year) vs 2.0/year (IQRs 1.0-2.75 per year), p=0.09]. Remission without proteinuria was significantly longer in patients treated with MMF; remission median was 8.5 month (IQRs 6.25-11.0 month) vs 4.5 month (IQRs 4.0-7.5 month), (p=0.014), similarly the average length of remission without corticosteroids was 6.0 months (IQRs 0.25-8.5 months) vs 3.0 months (IQRs 0.0-7.25) months (p=0.028). In children SRINS, 4/7 children MMF treatment was clinically ineffective. Side effects of the treatment were: leucopenia (n =10), hyperbilirubinemia (n = 3), gastrointestinal disorders (n = 1) and anemia (n = 1). Conclusion: This study confirmed the efficacy of the treatment with MMF in SDINR in comparison with previously used drugs, with a small number of side effects.
Authors and Affiliations
D Tomczyk, A Jander, J Mihailescu, M Tkaczyk
Keywords
Related Articles
- EP ID EP75173
- DOI -
- Views 148
- Downloads 0
The analysis of the level and trends of potential years of life lost due to diabetes in Poland in the years 2002-2013
<b>Introduction:</b> The industrial and socio-economic development is the direct cause of changes in major health threats in highly developed societies. Diabetes is a civilization disease and it depends on the impaired a...
An ergonomic assessment and fitness evaluation of young male tea factory workers in Dooars, West Bengal
Introduction: There are very few published reports on the heath status of tea garden workers of West Bengal, while reports on cardiorespiratory fineness and body composition of male tea factory workers is almost sc...
The gut immune system, inflammatory bowel diseases, and the body immune homeostasis: modern treatment strategies
The digestive tract is nowadays conceived as a barrier organ constituted by a mucosal membrane separating the gut lumen from the inner milieu. The gut lumen is laden by a myriad of antigens brought about by the diet, but...
AIDS and nutrition in patients
Introduction: AIDS is a viral infection that particularly affects the nutritional status of patients by complicating the absorption of nutrients and their metabolism. Purpose: The purpose of this retrospective study is t...
Quality of life and methods of coping with stress depending on the used form of therapy of rheumatoid arthritis treatment
Introduction: There are studies, which prove a positive influence of biological drugs on effects of medical therapy but there are few of them, which focus on aspects of quality of life and coping with stress. Purpose: T...